2026-04-17
Discover our practical guide to stable overexpression cell lines using HEK293 and CHO systems. Learn efficient selection, high-throughput screening, and reliable validation of gene expression via qPCR, Western blot, flow cytometry, and ELISA for research and bioproduction applications.
2026-04-10
Explore the molecular mechanisms behind protein extraction in proteomics, including chemical lysis, mechanical disruption, and fractionation strategies. NebulaBio provides advanced proteomics solutions and optimized workflows for high-quality protein isolation and analysis.
2026-04-03
Explore the mechanisms behind single B cell sorting platforms, including antigen-specific enrichment, single-cell amplification, and native VH/VL pair recovery. NebulaBio provides advanced solutions for monoclonal antibody discovery, B cell receptor sequencing, and high-efficiency antibody screening to accelerate biologics development.
2026-03-27
Hybridoma technology remains a gold standard for monoclonal antibody production. This article explains key principles including cell fusion, HAT selection, and limiting dilution cloning, which ensure highly uniform antibody-producing cell lines. NebulaBio provides professional hybridoma-based monoclonal antibody development services for research and therapeutic applications.
2026-03-20
Stable reporter cell lines are essential tools for monitoring signaling pathway activity in drug discovery and functional studies. This article provides a systematic overview of reporter cell line development in HEK293 and CHO hosts, highlighting reporter gene assays and pathway-specific readouts. NebulaBio offers custom stable reporter cell line development services.
2026-03-13
Explore the molecular topology of feline immunoglobulins, including IgG subclass differences, V(D)J recombination-driven antibody diversity, and structural adaptations in felinized antibody engineering. Chenhui Biotech provides advanced research tools and recombinant proteins to support immunology and antibody development studies.
2026-03-06
Stable gene knockdown cell lines enable long-term gene suppression for functional studies and therapeutic research. This article explains RNAi and CRISPRi technologies and how stable knockdown models are established in HEK293 and CHO cells. NebulaBio provides custom stable gene knockdown cell line development services for research and drug discovery.
2026-03-01
Advanced high-throughput antibody production platform integrating automated screening and recombinant expression systems. Rapid, scalable and parallel antibody generation solutions for research and therapeutic development programs.
2026-03-01
Professional recombinant antibody production services using advanced CHO and mammalian expression systems. Custom monoclonal antibody expression, scalable manufacturing and high-purity purification solutions for research and biopharmaceutical development.
2026-03-01
Professional antibody purification platform offering Protein A affinity chromatography, IgG purification and large-scale monoclonal antibody purification services. High-purity, scalable and GMP-compatible solutions for research and biopharmaceutical development.